Skip to main content
Clinical Trials/NCT01357044
NCT01357044CompletedNot Applicable

An Extract of Pomegranate Fruit and Galangal Rhizome Increases the Numbers of Motile Sperm: A Prospective, Randomised, Controlled, Double-Blinded Trial

Horsens Hospital1 site in 1 country70 target enrollmentStarted: May 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
70
Locations
1
Primary Endpoint
Count of motile sperm per ejaculate

Study Overview

Brief Summary

this is a prospective randomized placebo-controlled double-blinded trial investigating the effect of plant extracts from Alpinia galanga and Punica granatum on human semen quality. The investigators hypothesize that these plant extracts will improve semen quality.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Reduced semen quality

Exclusion Criteria

  • •Total count of motile sperm less than 1 million sperm/ejaculate or more than 200 million sperm/ejaculate

Arms & Interventions

Plant extracts

Active Comparator

Intervention: Extracts of Punica granatum and Alpinia galanga (Dietary Supplement)

Placebo

Placebo Comparator

Intervention: Placebo (Dietary Supplement)

Outcomes

Primary Outcomes

Count of motile sperm per ejaculate

Time Frame: Each participant is given plant extract for three months with flanking semen analyses.

Secondary Outcomes

  • Morphology: percentage of morphologically abnormal sperm in the ejaculate(Each participant is given plant extract for three months with flanking semen analyses.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jens Fedder

Professor

Horsens Hospital

Study Sites (1)

Loading locations...

Similar Trials